• Skip to main content
  • Skip to primary sidebar

An Inconvenient Truth: This Is a Woman

Don’t Get Angry, Get Active!

Hide Search

Hysterectomies in California have declined significantly

H. Sandra Chevalier-Batik · September 26, 2008 ·

Hysterectomy Less Frequent and Has Fewer Complications

By Kristina Fiore, Staff Writer, MedPage Today

Published: September 19, 2008

Reviewed by Zalman S. Agus, MD; Emeritus Professor

University of Pennsylvania School of Medicine.

DAVIS, Calif., Sept. 19 — Hysterectomies in California have declined significantly since the early 1990s, as have the rates of complications associated with them, researchers said here.


The incidence of hysterectomies for benign gynecologic conditions dropped 17.6% from 1991 through 2004 (P<0.001) just as changes in practice and shorter hospital stays were associated with fewer associated complications (P<0.001), Lloyd H. Smith, M.D., Ph.D., of the University of California Davis, and colleagues wrote in the September issue of Obstetrics & Gynecology.

Clinical and technical innovations provided less invasive alternatives to hysterectomy in the early 1990s, the researchers wrote. Procedures such as endometrial ablation for benign uterine conditions increased between 1990 and 1997, for example. At the same time, laparoscopically assisted vaginal hysterectomy became increasingly popular.

To assess the frequency and safety of hysterectomy, the researchers analyzed data on 649,758 women undergoing inpatient hysterectomy in California from 1991 through 2004 from the California Patient Discharge Database.

The incidence of laparoscopically assisted vaginal hysterectomy increased 12-fold, from 0.3 per 10,000 women per year in 1991 to 3.6 per 10,000 women per year in 1997, although incidence of the procedure declined to 3.0 per 10,000 women per year in 2004.

Study authors also said they found evidence of a learning curve by analyzing complications associated with laparoscopically assisted vaginal hysterectomy during its widespread introduction in California. Learning the procedure became mandatory in residency programs in the U.S., and newly trained surgeons entered practice with more experience in this procedure, study authors wrote.

There was also a significant 38.8% reduction (P<0.001) in the rate of total abdominal hysterectomy over the study period, while the incidence of subtotal hysterectomy jumped 17-fold. This was likely because of a perception that subtotal hysterectomy was associated with less risk of urinary incontinence and sexual dysfunction, the authors said.

Upgrades in surgical equipment or technique, and prevention of infection and venous thromboembolism, have improved the safety of hysterectomy, the researchers said. Combined with shorter hospital stays, these factors likely explain the decrease in complications such as bleeding and urinary or GI tract problems.

After controlling for several factors such as age, race, and comorbidities, the year that a patient had a hysterectomy was associated with reduced odds of medical and surgical complications.

For example, there was an increased risk of a urinary tract complication in 1995-1996 for patients undergoing laparoscopically assisted vaginal hysterectomy (OR 1.41, 95% CI 1.10 to 1.18), vaginal hysterectomy (OR 1.18, 95% CI 1.08 to 1.29), or total abdominal hysterectomy (OR 1.12, 95% CI 1.06 to 1.17), but that risk subsequently declined. Also, gastrointestinal tract complications peaked in the mid-1990s for the three procedures and then declined.

Researchers found statistically significant declines in the odds of bleeding complications for all hysterectomy types except total abdominal hysterectomy.

The length of hospital stay also decreased for each type of hysterectomy. Stays for laparoscopically assisted vaginal hysterectomy and vaginal hysterectomy dropped to two days from three, total abdominal hysterectomy to three days from four, and subtotal hysterectomy to two days from four.

Certain factors, however, were associated with an increased risk for complications: older age, African-American race, and the presence of comorbidities.

A primary diagnosis of fibroids was associated with higher odds of complications than other primary diagnoses, save for a primary diagnosis of infection, which was associated with the highest risk of surgical complications in total abdominal hysterectomy or subtotal hysterectomy.

Concurrent vaginal repair or urinary incontinence procedures were associated with the highest risk of urinary tract complications. For example, the odds of urinary tract injury associated with concurrent vaginal repair was elevated for laparoscopically assisted vaginal hysterectomy (OR 1.46, 95% CI 1.26 to 1.69), vaginal hysterectomy (OR 1.55, 95% CI 1.44 to 1.67), and total abdominal hysterectomy (OR 1.21, 95% CI 1.14 to 1.29). And the odds of urinary tract injury associated with concurrent urinary incontinence procedure were elevated for laparoscopically assisted vaginal hysterectomy (OR 1.24, 95% CI 1.04 to 1.48), vaginal hysterectomy (OR 1.34, 95% CI 1.25 to 1.43), and total abdominal hysterectomy (OR 1.25, 95% CI 1.18 to 1.32)

African-American race was associated with elevated odds of almost every category of medical and surgical complication compared with non-Hispanic whites. The study authors wrote that this disparity in outcomes warrants further study.

The authors acknowledged some limitations of the study, including that they were unable to analyze cases of hysterectomy that may have occurred in the outpatient setting in freestanding surgical centers, therefore possibly underestimating rates of hysterectomy in California. Also, the use of complication codes to analyze postoperative clinical outcomes might be limiting.

The study was supported by the Department of Obstetrics and Gynecology Research Fund at the University of California Davis. The authors had no potential conflicts of interest to disclose.

Primary source: Obstetrics & Gynecology

Source reference:

Smith LH, et al “Trends in the safety of inpatient hysterectomy for benign conditions in California, 1991-2004” Obstet & Gynecol 2008; 112(3): 553-561.

Share

Filed Under: Reproductive Health Tagged With: Hysterectomy, Reproductive Health, surgical equipment, urinary incontinence, Woman’s Health

Primary Sidebar

Categories

  • Attention-Deficit/Hyperactivity Disorder Medications
  • Big Pharma Watch
  • Biotech Industry
  • Birth Control
  • Breast Cancer
  • cáncer de cuello uterino
  • Cancer Research
  • Cervarix
  • Cervical Cancer
  • Clinical Trials
  • Diabetes
  • Domestic Violence
  • Drug Approvals
  • Emotional Health
  • FDA
  • FDA Black Box Warning
  • FDA Clinical Trials
  • FDA Failure To Protect
  • FDA Product Recall
  • Follow The Money
  • Gardasil
  • Gardasil®
  • Gender Bias
  • Gender Politics
  • genital warts
  • Guillain-Barre Syndrome
  • Hormone Cycle
  • HPV Infection
  • HPV Vaccine
  • HRT
  • HRT Side Effects
  • Influenza A Virus H1N1 Strain
  • Mammograms
  • Mandatory HPV Vaccination Policies
  • Medical Technology
  • Menopause
  • MERCK Watch
  • MMR vaccine
  • National Vaccine Injury Compensation Program
  • PAP Test
  • Prescription Drug Side Effects
  • Proactive Nutrition
  • Product Recall
  • Reproductive Health
  • Sexual Dysfunction
  • Sleep Loss
  • STD Infection
  • Stroke
  • Take Action!
  • Uncategorized
  • Unwanted Pregnancy
  • Vaccination Policy
  • VAERS
  • vaginal yeast infection
  • Virginity
  • Weight Gain
  • Women's Health
  • Women's Rights
  • Work Place Issues
  • World Health Organization
  • Yeast Infection
  • Your Body/Your Self

Archives

  • February 2010
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • March 2006
  • September 2005
  • June 2005
  • May 2005
  • December 2004
April 2025
S M T W T F S
 12345
6789101112
13141516171819
20212223242526
27282930  
« Feb    

Breast Cancer

  • Cancer Advocacy

Health Advocacy

  • Women’s Universal Health Initiative

Syndication

  • FDA MedWatch

Tags

Big Pharma Watch Birth Control Breast Cancer Cancer Cancer Research CDC Cervarix Cervical Cancer Children's Health Exploitive Behavior FDA FDA Approvals FDA Clinical Trials FDA Failure To Protect FDA Press Release Follow The Money Gardasil Gardasil Adverse Event Gardasil® GlaxoSmithKline GlaxoSmithKline Cervarix Gynecology H1N1 "swine flu" virus H1N1 pandemic influenza preparedness efforts Health Advisory HPV HPV-Associated Cervical Cancer HPV-Vaccination HPV Infection HPV Vaccine HRT Human Papillomavirus (HPV) Infection Merck PAP SMEAR PAP Test Proactive Nutrition Questionable Medicine STD Infection STD Vaccination swine flu vaccine Swine flu vaccine production Take Action! Uncategorized Woman’s Health Your Body/Your Self

Copyright © 2010-2025 Hands On WordPress · All Rights Reserved